Experience with denosumab (XGEVA®) for prevention of skeletal-related events in the 10 years after approval

Autor: Cadieux, Benoit, Coleman, Robert, Jafarinasabian, Pegah, Lipton, Allan, Orlowski, Robert Z., Saad, Fred, Scagliotti, Giorgio V., Shimizu, Kazuyuki, Stopeck, Alison
Zdroj: In Journal of Bone Oncology April 2022 33
Databáze: ScienceDirect